https://www.selleckchem.com/pr....oducts/pf-00835231.h
05). The mean time to walk the beam was reduced in group E1 by 2.6% compared to group E2 ( 0.05). The rearing frequency was increased in group E1 during week 6-7 compared to that in the period of CPZ treatment. The mean area of demyelination in the corpus callosum showed a 12% reduction in group E1 compared to group E2 ( 0.05). Short-term AT therapy showed improvement in motor dysfunction and reduction of demyelination in the animal model of MS. Short-term AT therapy showed improvement in motor dysfunction and reduction of